Clinical trial
A Phase I Study to Assess the Safety and Immunogenicity of the Polyprotein Malaria Vaccine Candidates FP9 PP and MVA PP in Healthy Adults Using a Prime-Boost Delivery Schedule
NCT00374998 is registered in ClinicalTrials.gov with European Vaccine Initiative as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study to Assess the Safety and Immunogenicity of the Polyprotein Malaria Vaccine Candidates FP9 PP and MVA PP in Healthy Adults Using a Prime-Boost Delivery Schedule
- Lead sponsor
- European Vaccine Initiative
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- April 30, 2006
- Completion date
- January 31, 2007
- Enrollment
- 35
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.